Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.prro.2024.04.005 | DOI Listing |
Cureus
October 2024
Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, USA.
Sci Rep
September 2024
Department of Biomedical Engineering, Keimyung University Department of Medical Informatics, School of Medicine, Keimyung University, Daegu, Korea.
To ensure the safety of medical personnel in healthcare organizations, radiation-shielding materials like protective clothing are used to protect against low-dose radiation, such as scattered rays. The extremities, particularly the hands, are the most exposed to radiation. New materials that can be directly coated onto the skin would be more cost-effective, efficient, and convenient than gloves.
View Article and Find Full Text PDFMil Med
August 2024
UMF Corporation, Skokie, IL 60076, USA.
Introduction: In light of the COVID-19 (Coronovirus Disease 2019) pandemic, the use of personal protective equipment has become essential to reduce viral transmission and maintain public health. Viruses, particularly human coronavirus and influenza, pose significant challenges because of their various transmission routes. UMF Corporation's innovation, Micrillon, aims to address these challenges by creating durable, antiviral technology for textiles without harmful chemicals, reducing viral transmission risks.
View Article and Find Full Text PDFZhongguo Gu Shang
June 2024
Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China.
Objective: To explore dose-effect relationship of biomechanical parameters in treating atlantoaxial joint disorder by slimming manipulation.
Methods: From October 2022 to May 2023, 18 patients with atlantoaxial joint disorders were treated, including 10 males and 8 females;aged from 24 to 27 years old with an average of (25.50±1.
Front Oncol
June 2024
First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Background: Chemotherapy-induced peripheral neurotoxicity (CIPN) is a dose-limiting side effect observed in breast cancer patients. Its primary clinical manifestations include limb numbness, tingling sensations, hypoesthesia, or paresthesia. In severe instances, some patients may also encounter muscle cramps, weakness, and pain, leading to potential paralysis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!